Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study

Title

Identifier

/unibl/sci/idNaucniRad:24182

616.36-002(497.6RS)

info:doi/10.5937/scriptamed50-22255

Type

See all items with this valueAcademic Article

See all items with this valuetext

Date

See all items with this value2019-02

Bibliographic Citation

A. Verhaz, Z. Kezić, R. Škrbić, M. Stoiljković, Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study, Scripta Medica, Vol. 50, No. 3, pp. 77 - 81, Feb, 2019

page start

page end

Is Part Of

See all items with this valueScripta Medica

See all items with this valuexxxx-xxxx

list of authors

See all items with this value Antonija Verhaz

See all items with this value Zdravka Kezić

See all items with this value Ranko Škrbić

See all items with this value Miloš Stoiljković

Relation

See all items with this value Medicinski fakultet

Position: 8643 (35 views)